Cargando…
Mediterranean Diet Implementation to Protect against Advanced Lung Cancer Index (ALI) Rise: Study Design and Preliminary Results of a Randomised Controlled Trial
The Mediterranean diet (MD) has been inversely associated with lung cancer (LC) risk. Hereby we show the preliminary results of our prospective randomised controlled trial in inflammatory and nutritional status of LC patients after 3-month implementation of MD. In total, 30 patients with small-cell...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036451/ https://www.ncbi.nlm.nih.gov/pubmed/33916252 http://dx.doi.org/10.3390/ijerph18073700 |
_version_ | 1783676913274847232 |
---|---|
author | Gioxari, Aristea Tzanos, Dimitrios Kostara, Christina Papandreou, Panos Mountzios, Giannis Skouroliakou, Maria |
author_facet | Gioxari, Aristea Tzanos, Dimitrios Kostara, Christina Papandreou, Panos Mountzios, Giannis Skouroliakou, Maria |
author_sort | Gioxari, Aristea |
collection | PubMed |
description | The Mediterranean diet (MD) has been inversely associated with lung cancer (LC) risk. Hereby we show the preliminary results of our prospective randomised controlled trial in inflammatory and nutritional status of LC patients after 3-month implementation of MD. In total, 30 patients with small-cell or non-small-cell LC (stages III–IV) were enrolled. They were randomly assigned either to Control group, receiving general nutritional guidelines, or the MD group, in which a personalised MD plan was provided. Medical and dietary history, anthropometrics, blood biomarkers, and circulating antioxidant vitamins were assessed. The main outcome was a significantly higher advanced lung cancer inflammation index (ALI) in patients of the control arm than those following MD (p = 0.003). In the MD group, platelets were significantly reduced at the study endpoint (p = 0.044). BMI and body fat mass remained unchanged in both arms, but serum glucose was significantly higher in control compared to MD group (p = 0.017). In conclusion, we showed for the first time that implementing a personalised MD for 3 months is promising to regulate prognostic biomarkers in advanced LC. The final results of our on-going trial will shed a light on the inflammatory, antioxidant and nutritional status of LC patients following MD. |
format | Online Article Text |
id | pubmed-8036451 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-80364512021-04-12 Mediterranean Diet Implementation to Protect against Advanced Lung Cancer Index (ALI) Rise: Study Design and Preliminary Results of a Randomised Controlled Trial Gioxari, Aristea Tzanos, Dimitrios Kostara, Christina Papandreou, Panos Mountzios, Giannis Skouroliakou, Maria Int J Environ Res Public Health Article The Mediterranean diet (MD) has been inversely associated with lung cancer (LC) risk. Hereby we show the preliminary results of our prospective randomised controlled trial in inflammatory and nutritional status of LC patients after 3-month implementation of MD. In total, 30 patients with small-cell or non-small-cell LC (stages III–IV) were enrolled. They were randomly assigned either to Control group, receiving general nutritional guidelines, or the MD group, in which a personalised MD plan was provided. Medical and dietary history, anthropometrics, blood biomarkers, and circulating antioxidant vitamins were assessed. The main outcome was a significantly higher advanced lung cancer inflammation index (ALI) in patients of the control arm than those following MD (p = 0.003). In the MD group, platelets were significantly reduced at the study endpoint (p = 0.044). BMI and body fat mass remained unchanged in both arms, but serum glucose was significantly higher in control compared to MD group (p = 0.017). In conclusion, we showed for the first time that implementing a personalised MD for 3 months is promising to regulate prognostic biomarkers in advanced LC. The final results of our on-going trial will shed a light on the inflammatory, antioxidant and nutritional status of LC patients following MD. MDPI 2021-04-01 /pmc/articles/PMC8036451/ /pubmed/33916252 http://dx.doi.org/10.3390/ijerph18073700 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Gioxari, Aristea Tzanos, Dimitrios Kostara, Christina Papandreou, Panos Mountzios, Giannis Skouroliakou, Maria Mediterranean Diet Implementation to Protect against Advanced Lung Cancer Index (ALI) Rise: Study Design and Preliminary Results of a Randomised Controlled Trial |
title | Mediterranean Diet Implementation to Protect against Advanced Lung Cancer Index (ALI) Rise: Study Design and Preliminary Results of a Randomised Controlled Trial |
title_full | Mediterranean Diet Implementation to Protect against Advanced Lung Cancer Index (ALI) Rise: Study Design and Preliminary Results of a Randomised Controlled Trial |
title_fullStr | Mediterranean Diet Implementation to Protect against Advanced Lung Cancer Index (ALI) Rise: Study Design and Preliminary Results of a Randomised Controlled Trial |
title_full_unstemmed | Mediterranean Diet Implementation to Protect against Advanced Lung Cancer Index (ALI) Rise: Study Design and Preliminary Results of a Randomised Controlled Trial |
title_short | Mediterranean Diet Implementation to Protect against Advanced Lung Cancer Index (ALI) Rise: Study Design and Preliminary Results of a Randomised Controlled Trial |
title_sort | mediterranean diet implementation to protect against advanced lung cancer index (ali) rise: study design and preliminary results of a randomised controlled trial |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036451/ https://www.ncbi.nlm.nih.gov/pubmed/33916252 http://dx.doi.org/10.3390/ijerph18073700 |
work_keys_str_mv | AT gioxariaristea mediterraneandietimplementationtoprotectagainstadvancedlungcancerindexalirisestudydesignandpreliminaryresultsofarandomisedcontrolledtrial AT tzanosdimitrios mediterraneandietimplementationtoprotectagainstadvancedlungcancerindexalirisestudydesignandpreliminaryresultsofarandomisedcontrolledtrial AT kostarachristina mediterraneandietimplementationtoprotectagainstadvancedlungcancerindexalirisestudydesignandpreliminaryresultsofarandomisedcontrolledtrial AT papandreoupanos mediterraneandietimplementationtoprotectagainstadvancedlungcancerindexalirisestudydesignandpreliminaryresultsofarandomisedcontrolledtrial AT mountziosgiannis mediterraneandietimplementationtoprotectagainstadvancedlungcancerindexalirisestudydesignandpreliminaryresultsofarandomisedcontrolledtrial AT skouroliakoumaria mediterraneandietimplementationtoprotectagainstadvancedlungcancerindexalirisestudydesignandpreliminaryresultsofarandomisedcontrolledtrial |